These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9834944)

  • 1. Aqueous-based polymeric dispersion: face-centered cubic design for the development of atenolol gastrointestinal therapeutic system.
    Sastry SV; Khan MA
    Pharm Dev Technol; 1998 Nov; 3(4):423-32. PubMed ID: 9834944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous based polymeric dispersion: Plackett--Burman design for screening of formulation variables of atenolol gastrointestinal therapeutic system.
    Sastry SV; Khan MA
    Pharm Acta Helv; 1998 Jul; 73(2):105-12. PubMed ID: 9700939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term stability characterization of a controlled release gastrointestinal therapeutic system coated with a cellulose acetate pseudolatex.
    Vaithiyalingam SR; Sastry SV; Dehon RH; Reddy IK; Khan MA
    Pharmazie; 2001 Jan; 56(1):66-9. PubMed ID: 11210674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology.
    Singh B; Chakkal SK; Ahuja N
    AAPS PharmSciTech; 2006 Jan; 7(1):E3. PubMed ID: 16584161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention.
    Narendra C; Srinath MS; Babu G
    AAPS PharmSciTech; 2006 Apr; 7(2):E34. PubMed ID: 16796352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central composite design for the formulation and optimization of a multi-unit potential colonic drug delivery system of budesonide for ulcerative colitis.
    Patel NV; Patel JK; Shah SH; Patel JN
    Pharmazie; 2011 Feb; 66(2):124-9. PubMed ID: 21434575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Box-Behnken design in understanding the quality of genistein self-nanoemulsified drug delivery systems and optimizing its formulation.
    Zhu S; Hong M; Liu C; Pei Y
    Pharm Dev Technol; 2009; 14(6):642-9. PubMed ID: 19883253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of propranolol hydrochloride sustained-release pellets using box-behnken design and desirability function.
    Bodea A; Leucuta SE
    Drug Dev Ind Pharm; 1998 Feb; 24(2):145-55. PubMed ID: 15605444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization and characterization of controlled release multi-particulate beads coated with starch acetate.
    Nutan MT; Soliman MS; Taha EI; Khan MA
    Int J Pharm; 2005 Apr; 294(1-2):89-101. PubMed ID: 15814233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response surface methodology for the optimization of ubiquinone self-nanoemulsified drug delivery system.
    Nazzal S; Khan MA
    AAPS PharmSciTech; 2002; 3(1):E3. PubMed ID: 12916956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric floating matrix tablets: design and optimization using combination of polymers.
    Prajapati ST; Patel LD; Patel DM
    Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
    Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
    Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An approach to formulating an oral floating drug delivery system for dexchlorpheniramine maleate using factorial design.
    Alabazi MY; Elzein H
    Pharmazie; 2012 Jul; 67(7):611-7. PubMed ID: 22888518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubility-modulated monolithic osmotic pump tablet for atenolol delivery.
    Liu L; Wang X
    Eur J Pharm Biopharm; 2008 Feb; 68(2):298-302. PubMed ID: 17560099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation design and characterization of an elementary osmotic pump tablet of flurbiprofen.
    Patel KN; Mehta TA
    PDA J Pharm Sci Technol; 2014; 68(4):333-46. PubMed ID: 25035256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of atenolol monolithic osmotic pump tablets].
    Liu LX; Che BJ; Xu Q
    Yao Xue Xue Bao; 2006 May; 41(5):457-60. PubMed ID: 16848324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan-based controlled porosity osmotic pump for colon-specific delivery system: screening of formulation variables and in vitro investigation.
    Liu H; Yang XG; Nie SF; Wei LL; Zhou LL; Liu H; Tang R; Pan WS
    Int J Pharm; 2007 Mar; 332(1-2):115-24. PubMed ID: 17052871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of monolithic osmotic pump system by coating the indented core tablet.
    Liu L; Che B
    Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naproxen-Eudragit microspheres: screening of process and formulation variables for the preparation of extended release tablets.
    Zaghloul AA; Faltinek J; Vaithiyalingam SR; Reddy IK; Khan MA
    Pharmazie; 2001 Apr; 56(4):321-4. PubMed ID: 11338673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.